title: Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
abstract: Organisms belonging to the Streptococcus milleri group (SMG) are known for their role in pyogenic infections but have recently been implicated as etiological agents of pulmonary exacerbation in adult patients with cystic fibrosis (CF). The prolonged exposure of CF patients to antibiotics prompted us to investigate the susceptibility profiles of 118 SMG isolates from the airways of CF patients to 12 antibiotics compared to 43 SMG isolates from patients with invasive infections. We found that approximately 60% of all isolates failed to grow using the standard medium for disc diffusion, Mueller-Hinton blood agar (MHBA), so we explored the usefulness of brain heart infusion (BHI) agar for susceptibility testing. Zone-of-inhibition comparisons between BHI and MHBA showed strong correlations for six antibiotics, and interpretations were similar for both medium types. For ceftriaxone and cefepime, both groups of isolates were highly susceptible. Tetracycline resistance levels were comparable between the two groups (22% in CF isolates and 17.4% in invasive isolates). However, more than half of the CF isolates were not susceptible to azithromycin, erythromycin, and clindamycin, compared to 11%, 13%, and 6.5% of invasive isolates, respectively. There were 5-fold and 8-fold increased risks of azithromycin and clindamycin resistance, respectively, for the isolates from the airways of CF patients relative to the invasive isolates. Macrolide resistance was strongly linked to chronic azithromycin therapy in CF patients. This study shows that BHI agar is a suitable alternative for antimicrobial susceptibility testing for the SMG and that SMG isolates from the airways of CF patients are more resistant to macrolides and clindamycin than strains isolated from patients with invasive infections.
authors.affiliation: Department of Microbiology and Infectious Diseases, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada.
authors.forename: Margot E
authors.initials: ME
authors.lastname: Grinwis
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Sibley
authors.forename: Michael D
authors.initials: MD
authors.lastname: Parkins
authors.forename: Christina S
authors.initials: CS
authors.lastname: Eshaghurshan
authors.forename: Harvey R
authors.initials: HR
authors.lastname: Rabin
authors.forename: Michael G
authors.initials: MG
authors.lastname: Surette
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D017963:Azithromycin / Q000494:pharmacology / Q000627:therapeutic use; D002981:Clindamycin / Q000494:pharmacology / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D004917:Erythromycin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D018942:Macrolides / Q000494:pharmacology / Q000627:therapeutic use*; D034364:Streptococcus milleri Group / Q000187:drug effects*; D013752:Tetracycline / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D002981:Clindamycin; D004917:Erythromycin; D017963:Azithromycin; D013752:Tetracycline
references.citation: J Infect Chemother. 2002 Jun;8(2):134-7
references.pmid: 12111565
references.citation: Clin Microbiol Infect. 2006 Mar;12(3):224-30
references.pmid: 16451408
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15070-5
references.pmid: 18812504
references.citation: J Infect Dis. 1979 Sep;140(3):316-21
references.pmid: 501146
references.citation: Pediatr Pulmonol. 2008 May;43(5):490-7
references.pmid: 18383109
references.citation: Antimicrob Agents Chemother. 2001 May;45(5):1511-4
references.pmid: 11302819
references.citation: Pediatr Infect Dis J. 2007 Jan;26(1):8-12
references.pmid: 17195698
references.citation: J Med Microbiol. 2009 Feb;58(Pt 2):222-227
references.pmid: 19141740
references.citation: J Pediatr. 2002 Mar;140(3):299-305
references.pmid: 11953726
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20529-33
references.pmid: 18077362
references.citation: Diagn Microbiol Infect Dis. 1994 Jun;19(2):69-73
references.pmid: 7805358
references.citation: Am J Med. 2006 Oct;119(10):877-83
references.pmid: 17000220
references.citation: Eye (Lond). 2000 Oct;14 Pt 5:814-5
references.pmid: 11116727
references.citation: JAMA. 2003 Oct 1;290(13):1749-56
references.pmid: 14519709
references.citation: J Antimicrob Chemother. 1987 Jun;19(6):831-8
references.pmid: 3301785
references.citation: Curr Opin Investig Drugs. 2009 Aug;10(8):787-94
references.pmid: 19649923
references.citation: Lancet. 2002 Sep 28;360(9338):978-84
references.pmid: 12383667
references.citation: Ann Trop Paediatr. 2006 Dec;26(4):285-91
references.pmid: 17132293
references.citation: Eur J Clin Microbiol Infect Dis. 1999 Jun;18(6):440-4
references.pmid: 10442424
references.citation: Am J Respir Crit Care Med. 2007 Nov 15;176(10):957-69
references.pmid: 17761616
references.citation: Br Med J. 1977 Oct 15;2(6093):981-4
references.pmid: 336141
references.citation: Antimicrob Agents Chemother. 1995 Oct;39(10):2243-7
references.pmid: 8619576
references.citation: Br Med J (Clin Res Ed). 1981 Sep 26;283(6295):819-21
references.pmid: 6794712
references.citation: Clin Microbiol Rev. 1988 Jan;1(1):102-8
references.pmid: 3060239
references.citation: Am Surg. 2007 May;73(5):492-7
references.pmid: 17521006
references.citation: Thorax. 2000 Mar;55(3):251-2
references.pmid: 10744544
references.citation: Eur Respir J. 1998 Aug;12(2):357-62
references.pmid: 9727785
references.citation: J Med Microbiol. 2010 May;59(Pt 5):534-540
references.pmid: 20093379
references.citation: J Antimicrob Chemother. 2006 Apr;57(4):741-6
references.pmid: 16469851
references.citation: J Antimicrob Chemother. 2009 Sep;64(3):501-6
references.pmid: 19584106
references.citation: Eur J Clin Microbiol Infect Dis. 2007 Jan;26(1):1-11
references.pmid: 17180609
references.citation: Eur J Clin Microbiol Infect Dis. 1998 Aug;17(8):556-60
references.pmid: 9796653
references.citation: Thorax. 1995 Oct;50(10):1093-6
references.pmid: 7491559
references.citation: Chest. 1998 Dec;114(6):1588-93
references.pmid: 9872193
references.citation: J Cyst Fibros. 2009 Jan;8(1):58-62
references.pmid: 18849202
references.citation: Arch Dis Child. 1999 Mar;80(3):278-9
references.pmid: 10325713
references.citation: Antimicrob Agents Chemother. 2001 Aug;45(8):2375-7
references.pmid: 11451701
references.citation: Antimicrob Agents Chemother. 1995 Mar;39(3):577-85
references.pmid: 7793855
references.citation: Clin Infect Dis. 1995 Dec;21 Suppl 3:S238-43
references.pmid: 8749672
references.citation: Antimicrob Agents Chemother. 1996 Apr;40(4):891-4
references.pmid: 8849246
references.citation: N Engl J Med. 1993 Jun 17;328(24):1740-6
references.pmid: 8497284
references.citation: Pediatr Infect Dis J. 2002 Aug;21(8):715-23
references.pmid: 12192158
references.citation: J Clin Microbiol. 1996 Aug;34(8):2020-2
references.pmid: 8818904
references.citation: Thorax. 2002 Mar;57(3):212-6
references.pmid: 11867823
references.citation: Jpn J Infect Dis. 2008 Nov;61(6):484-6
references.pmid: 19050362
references.citation: J Clin Microbiol. 2010 Feb;48(2):395-401
references.pmid: 20007382
references.citation: J Antimicrob Chemother. 1999 Mar;43(3):399-402
references.pmid: 10223596
references.citation: Antimicrob Agents Chemother. 1991 Jul;35(7):1267-72
references.pmid: 1929280